Literature DB >> 23942610

Association of Asian ethnicity with disease activity in SLE: an observational study from the Monash Lupus Clinic.

V Golder1, K Connelly, M Staples, E Morand, A Hoi.   

Abstract

OBJECTIVE: Systemic lupus erythematosus (SLE), an autoimmune condition with diverse clinical manifestations, is reported to have different expression in populations of different ancestry. Most previous studies compared patients of different ethnic groups from geographically distinct cohorts. In our study, we aimed to characterize disease manifestations in patients of different ethnic groups from a single centre, and studied patterns of disease activity over time.
METHODS: Demographics, baseline disease characteristics and autoantibody profiles, and disease activity (SLEDAI) measured at each visit, were captured from all consenting patients prospectively followed between 2007 and 2011 in an urban teaching hospital lupus clinic. Ethnicity was self-reported.
RESULTS: Asian ethnicity was significantly associated with more clinically severe SLE. Time-adjusted mean SLEDAI (p = 0.01) and maximum SLEDAI (p = 0.0018) were significantly higher in Asian patients. Asians were more likely to have renal disease (OR 2.9, 95% CI 1.4-5.98; p = 0.004) and persistently active disease (PAD) (OR 2.14, 95% CI 1.05-4.38, p = 0.04). Asian lupus patients also had a significantly higher proportion of autoantibody positivity to anti-dsDNA, anti-RNP, anti-Sm, anti-Ro and anti-La, as well as increased likelihood of hypocomplementaemia and immunosuppressant use.
CONCLUSION: In this single-cohort study, Asian ethnicity was found to be associated with increased SLE disease activity. This suggests significant inter-ethnic genetic contributions to the regulation of autoimmune responses and disease severity in SLE.

Entities:  

Keywords:  Systemic lupus erythematosus; anti-DNA antibodies; renal lupus

Mesh:

Substances:

Year:  2013        PMID: 23942610     DOI: 10.1177/0961203313500547

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  23 in total

1.  Systemic lupus erythematosus and malignancies risk.

Authors:  Song Mao; Hua Shen; Jianhua Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2015-08-29       Impact factor: 4.553

Review 2.  Successes, challenges and developments in Australian rheumatology.

Authors:  Eric F Morand; Michelle T Leech
Journal:  Nat Rev Rheumatol       Date:  2015-03-10       Impact factor: 20.543

Review 3.  The BAFF/APRIL system in SLE pathogenesis.

Authors:  Fabien B Vincent; Eric F Morand; Pascal Schneider; Fabienne Mackay
Journal:  Nat Rev Rheumatol       Date:  2014-03-11       Impact factor: 20.543

4.  Defining biological subsets in systemic lupus erythematosus: progress toward personalized therapy.

Authors:  Nailú Angélica Sinicato; Mariana Postal; Simone Appenzeller; Timothy B Niewold
Journal:  Pharmaceut Med       Date:  2017-01-25

Review 5.  The need to define treatment goals for systemic lupus erythematosus.

Authors:  Kate Franklyn; Alberta Hoi; Mandana Nikpour; Eric F Morand
Journal:  Nat Rev Rheumatol       Date:  2014-07-22       Impact factor: 20.543

Review 6.  Lupus Nephritis: A Different Disease in European Patients?

Authors:  Vladimir Tesar; Zdenka Hruskova
Journal:  Kidney Dis (Basel)       Date:  2015-08-28

7.  Urinary B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL): potential biomarkers of active lupus nephritis.

Authors:  S Phatak; S Chaurasia; S K Mishra; R Gupta; V Agrawal; A Aggarwal; R Misra
Journal:  Clin Exp Immunol       Date:  2016-12-05       Impact factor: 4.330

8.  Association of clinic setting with quality indicator performance in systemic lupus erythematosus: a cross-sectional study.

Authors:  Sidha Sreedharan; Ning Li; Geoff Littlejohn; Russell Buchanan; Mandana Nikpour; Eric Morand; Alberta Hoi; Vera Golder
Journal:  Arthritis Res Ther       Date:  2022-06-22       Impact factor: 5.606

9.  High Disease Severity Among Asian Patients in a US Multiethnic Cohort of Individuals With Systemic Lupus Erythematosus.

Authors:  Kimberly DeQuattro; Laura Trupin; Louise B Murphy; Stephanie Rush; Lindsey A Criswell; Cristina M Lanata; Maria Dall'Era; Patricia Katz; Jinoos Yazdany
Journal:  Arthritis Care Res (Hoboken)       Date:  2022-04-20       Impact factor: 5.178

10.  Risk factors for the flare of systemic lupus erythematosus and its influence on prognosis: a single-center retrospective analysis.

Authors:  Xiaohong Zeng; Ling Zheng; Hongbing Rui; Rihui Kang; Junmin Chen; Huaning Chen; Jizan Liu
Journal:  Adv Rheumatol       Date:  2021-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.